About Event

The Only Industry-Focused Gene Editing Meeting

By spotlighting the emerging cutting-edge technologies, whilst also battling the key challenges limiting preclinical and clinical success, the 6th Genome Editing Therapeutics Summit seeks to provide your team with the insights needed to maximize the potential for your therapies.  

Collaborate with senior experts working across discovery, R&D, delivery, preclinical and clinical development, to streamline your end-to-end development. Hear the latest data, from novel technologies and innovative platforms through to the leading clinical programs, to support you in building robust strategies to break new therapeutic ground.  

QUICK PROGRAM DOWNLOAD

The 2025 Meeting at a Glance – What Not to Miss

Leverage learnings from leading assets to support your team in building unbreakable clinical strategies with Bluebird Bio

Identify innovative technology platforms to improve editing accessibility and  therapeutic safety with nChromaBio and Metagenomi

Evaluate the benefits of viral and non-viral approaches to mediate precise targeting with Mammoth Biosciences and nChromaBio

Enhance translatability and boost scalability through biomarker discovery with Modalis Therapeutics and Apellis Pharmaceuticals

Discuss approaches to accelerate progression from discovery through to commercialization with Prime Medicine and Novartis

Connect with Leading Experts

6th Genome Editing Therapeutics Summit - Companies in the Room 3

“I am excited to be a part of this summit, which brings together leading voices in this rapidly evolving field. This meeting provides a timely platform to explore how we can innovate and translate these tools into safe and effective therapies for patients”

Anna Gough, Scientist, Tune Therapeutics, 2025 Speaker 

SEE EVENT PROGRAM
REGISTER
PARTNER